Why the study?
Lung cancer myocardial metastasis is rare, and diagnosis and treatment outcomes with osimertinib in T790M mutation-positive cases are not well documented.
Case Report (n=1)
No
Osimertinib can be an effective treatment for myocardial metastasis in patients with T790M mutation-positive lung adenocarcinoma, leading to tumor shrinkage and resolution of ECG abnormalities.
May treat myocardial metastasis in T790M lung adenocarcinoma; single case leaves open need for prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Murakami et al. (2020) conducted a case report in Lung adenocarcinoma with myocardial metastasis (n=1). Osimertinib was evaluated on Tumor size and electrocardiogram changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: